Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study

Jonas Willmann, Nicolaus Andratschke, Matthias Gückenberger et al.|Radiotherapy and Oncology|2022

Cited by 46